Innovation Advisory Board

Adele Gulfo

  • Chief Strategy Officer, Mylan

Adele Gulfo serves as Mylan’s Chief Strategy Officer and is a director of Bemis, Inc. (BMS) serving on the company’s Audit Committee. As a member of Mylan’s Executive Leadership Team, she focuses on their key growth drivers, including the company’s expansion into new geographies and the development and growth of its global Specialty pharmaceutical franchise. Previously, Gulfo served as president and general manager of Pfizer’s U.S. Primary Care business unit, which included the Managed Markets and Commercial Operations for all of Pfizer’s Biopharmaceutical business units. Under her leadership, Pfizer’s U.S. Primary Care business generated more than $13 billion in revenue. Earlier in her career at Pfizer, Gulfo was instrumental in the development, launch and commercial success of LIPITOR, which became the world’s best-selling medicine. She was also recognized for her leadership in marketing and medical education campaigns that helped to establish the significance of lowering cholesterol in preventing and managing heart disease.

Back to Innovation Advisory Board